Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026)

Quarterly results put Amortizatization of Intangibles at $39189.0 for Q1 2026, up 86.37% from a year ago — trailing twelve months through Mar 2026 was $136916.0 (up 65.69% YoY), and the annual figure for FY2025 was $118754.0, up 44.04%.

Immix Biopharma has reported Amortizatization of Intangibles over the past 4 years, most recently at $39189.0 for Q1 2026.

  • Amortizatization of Intangibles reached $39189.0 in Q1 2026 per IMMX's latest filing, up from $38517.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $39189.0 in Q1 2026 and bottomed at $20416.0 in Q2 2024.
  • Median Amortizatization of Intangibles over the past 3 years was $21027.0 (2025), compared with a mean of $26710.0.
  • The largest annual shift saw Amortizatization of Intangibles rose 0.9% in 2025 before it surged 86.37% in 2026.
  • Over 3 years, Amortizatization of Intangibles stood at $20734.0 in 2024, then soared by 85.77% to $38517.0 in 2025, then rose by 1.74% to $39189.0 in 2026.
  • Business Quant data shows Amortizatization of Intangibles for IMMX at $39189.0 in Q1 2026, $38517.0 in Q4 2025, and $37869.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 13,267.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Immix Biopharma 476.17 Mn 476.17 Mn - 39,189.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39,189.00
Mar 31, 2026 39,189.00
Dec 31, 2025 38,517.00
Dec 31, 2025 38,517.00
Sep 30, 2025 37,869.00
Sep 30, 2025 37,869.00
Jun 30, 2025 21,341.00
Jun 30, 2025 21,341.00
Mar 31, 2025 21,027.00
Mar 31, 2025 21,027.00
Dec 31, 2024 20,734.00
Dec 31, 2024 20,734.00
Sep 30, 2024 20,457.00
Sep 30, 2024 20,457.00
Jun 30, 2024 20,416.00
Jun 30, 2024 20,416.00
Mar 31, 2024 20,840.00
Mar 31, 2024 20,840.00
Dec 31, 2021 16,619.00
Dec 31, 2021 16,619.00
Sep 30, 2021 20,121.00
Sep 30, 2021 20,121.00
Jun 30, 2021 19,726.00
Jun 30, 2021 19,726.00
Mar 31, 2021 1,691.00
Mar 31, 2021 1,691.00